UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

CSF biomarkers and clinical progression of Parkinson disease

Neurology, 2015-01, Vol.84 (1), p.57

2015

Volltextzugriff (PDF)

Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease

Movement disorders, 2016-06, Vol.31 (6), p.898-905

2016

Volltextzugriff (PDF)

Cerebrospinal fluid concentrations of inflammatory markers in Parkinson's disease and atypical parkinsonian disorders

Scientific reports, 2018-09, Vol.8 (1), p.13276-9, Article 13276

2018

Volltextzugriff (PDF)

The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies

PloS one, 2015-08, Vol.10 (8), p.e0135458-e0135458

2015

Volltextzugriff (PDF)

Low CSF levels of both α-synuclein and the α-synuclein cleaving enzyme neurosin in patients with synucleinopathy

PloS one, 2013, Vol.8 (1), p.e53250-e53250

2013

Volltextzugriff (PDF)

Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders

Movement disorders, 2020-03, Vol.35 (3), p.513-518

2020

Volltextzugriff (PDF)

Mapping of apparent susceptibility yields promising diagnostic separation of progressive supranuclear palsy from other causes of parkinsonism

Scientific reports, 2019-04, Vol.9 (1), p.6079-6079, Article 6079

2019

Volltextzugriff (PDF)

Alterations of Diffusion Kurtosis and Neurite Density Measures in Deep Grey Matter and White Matter in Parkinson's Disease

PloS one, 2016-06, Vol.11 (6), p.e0157755-e0157755

2016

Volltextzugriff (PDF)

Proinflammatory cytokines are elevated in serum of patients with multiple system atrophy

PloS one, 2013-04, Vol.8 (4), p.e62354-e62354

2013

Volltextzugriff (PDF)

Alteration of putaminal fractional anisotropy in Parkinson’s disease: a longitudinal diffusion kurtosis imaging study

Neuroradiology, 2018-03, Vol.60 (3), p.247-254

2018

Volltextzugriff (PDF)

Assessment of global and regional diffusion changes along white matter tracts in parkinsonian disorders by MR tractography

PloS one, 2013-06, Vol.8 (6), p.e66022-e66022

2013

Volltextzugriff (PDF)

Cerebrospinal fluid inflammatory markers in Parkinson’s disease – Associations with depression, fatigue, and cognitive impairment

Brain, behavior, and immunity, 2013-10, Vol.33 (Jul.,31), p.183-189

2013

Volltextzugriff (PDF)

P3‐270: CEREBROSPINAL FLUID CONCENTRATIONS OF INFLAMMATORY MARKERS IN PARKINSON'S DISEASE AND ATYPICAL PARKINSONIAN DISORDERS

Alzheimer's & dementia, 2018-07, Vol.14 (7S_Part_22), p.P1180-P1180

2018

Volltextzugriff (PDF)

CEREBROSPINAL FLUID CONCENTRATIONS OF INFLAMMATORY MARKERS IN PARKINSON’S DISEASE AND ATYPICAL PARKINSONIAN DISORDERS

Alzheimer's & dementia, 2018-07, Vol.14 (7), p.P1180-P1180

2018

Volltextzugriff (PDF)

Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy

Neuroradiology, 2015-11, Vol.57 (11), p.1079-1091

2015

Volltextzugriff (PDF)

L ongitudinal M easurements of C erebrospinal F luid B iomarkers in P arkinson's D isease

Movement disorders, 2016-06, Vol.31 (6), p.898-905

2016

Volltextzugriff (PDF)

P1‐144: HIGH CSF A‐SYNUCLEIN IS ASSOCIATED WITH CLINICAL PROGRESSION IN PD PATIENTS

Alzheimer's & dementia, 2014-07, Vol.10 (4S_Part_9), p.P353-P353

2014

Volltextzugriff (PDF)

HIGH CSF A-SYNUCLEIN IS ASSOCIATED WITH CLINICAL PROGRESSION IN PD PATIENTS

Alzheimer's & dementia, 2014-07, Vol.10 (4), p.P353-P353

2014

Volltextzugriff (PDF)

Dynamic susceptibility contrast MRI with a prebolus contrast agent administration design for improved absolute quantification of perfusion

Magnetic resonance in medicine, 2014-10, Vol.72 (4), p.996-1006

2014

Volltextzugriff (PDF)

Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders

Archives of neurology (Chicago), 2012-11, Vol.69 (11), p.1445

2012

Volltextzugriff (PDF)

Low levels of soluble NG2 in cerebrospinal fluid from patients with dementia with Lewy bodies

Journal of Alzheimer's disease, 2014-01, Vol.40 (2), p.343

2014

Volltextzugriff (PDF)

Dynamic susceptibility contrast MRI with a prebolus contrast agent administration design for improved absolute quantification of perfusion: Prebolus DSC-MRI for Quantification of Perfusion

Magnetic resonance in medicine, 2014-10, Vol.72 (4), p.996-1006

2014

Volltextzugriff (PDF)

INCREASED LEVELS OF ANGIOGENIC FACTORS IN THE CEREBROSPINAL FLUID ARE ASSOCIATED WITH COGNITIVE IMPAIRMENT IN PARKINSOŃS DISEASE

Alzheimer's & dementia, 2014-07, Vol.10 (4), p.P791-P791

2014

Volltextzugriff (PDF)

Low CSF Levels of Both [alpha]-Synuclein and the [alpha]-Synuclein Cleaving Enzyme Neurosin in Patients with Synucleinopathy

PloS one, 2013-01, Vol.8 (1), p.e53250

2013

Volltextzugriff (PDF)

Reduction of arterial partial volume effects for improved absolute quantification of DSC-MRI perfusion estimates: Comparison between tail scaling and prebolus administration

Journal of magnetic resonance imaging, 2015-04, Vol.41 (4), p.903-908

2015

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

CSF biomarkers and clinical progression of Parkinson disease

Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease

Cerebrospinal fluid concentrations of inflammatory markers in Parkinson's disease and atypical parkinsonian disorders

The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies

Low CSF levels of both α-synuclein and the α-synuclein cleaving enzyme neurosin in patients with synucleinopathy

Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders

Mapping of apparent susceptibility yields promising diagnostic separation of progressive supranuclear palsy from other causes of parkinsonism

Alterations of Diffusion Kurtosis and Neurite Density Measures in Deep Grey Matter and White Matter in Parkinson's Disease

Proinflammatory cytokines are elevated in serum of patients with multiple system atrophy

Alteration of putaminal fractional anisotropy in Parkinson’s disease: a longitudinal diffusion kurtosis imaging study

Assessment of global and regional diffusion changes along white matter tracts in parkinsonian disorders by MR tractography

Cerebrospinal fluid inflammatory markers in Parkinson’s disease – Associations with depression, fatigue, and cognitive impairment

P3‐270: CEREBROSPINAL FLUID CONCENTRATIONS OF INFLAMMATORY MARKERS IN PARKINSON'S DISEASE AND ATYPICAL PARKINSONIAN DISORDERS

CEREBROSPINAL FLUID CONCENTRATIONS OF INFLAMMATORY MARKERS IN PARKINSON’S DISEASE AND ATYPICAL PARKINSONIAN DISORDERS

Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy

L ongitudinal M easurements of C erebrospinal F luid B iomarkers in P arkinson's D isease

P1‐144: HIGH CSF A‐SYNUCLEIN IS ASSOCIATED WITH CLINICAL PROGRESSION IN PD PATIENTS

HIGH CSF A-SYNUCLEIN IS ASSOCIATED WITH CLINICAL PROGRESSION IN PD PATIENTS

Dynamic susceptibility contrast MRI with a prebolus contrast agent administration design for improved absolute quantification of perfusion

Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders

Low levels of soluble NG2 in cerebrospinal fluid from patients with dementia with Lewy bodies

Dynamic susceptibility contrast MRI with a prebolus contrast agent administration design for improved absolute quantification of perfusion: Prebolus DSC-MRI for Quantification of Perfusion

INCREASED LEVELS OF ANGIOGENIC FACTORS IN THE CEREBROSPINAL FLUID ARE ASSOCIATED WITH COGNITIVE IMPAIRMENT IN PARKINSOŃS DISEASE

Low CSF Levels of Both [alpha]-Synuclein and the [alpha]-Synuclein Cleaving Enzyme Neurosin in Patients with Synucleinopathy

Reduction of arterial partial volume effects for improved absolute quantification of DSC-MRI perfusion estimates: Comparison between tail scaling and prebolus administration

Suchergebnisse filtern